You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

11 Results
Guidelines and Advice
Status: Archived
ID: 12-3
Jan 2003
Guidelines and Advice
Status: Archived
ID: 13-2
Mar 2003
Guidelines and Advice
Status: Archived
ID: 13-1
Aug 2003
Guidelines and Advice
Status: Archived
ID: 5-6b
Jan 2003
Statistical Reports
Dec 2003
Statistical Reports
May 2003
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Funding:
Exceptional Access Program
    First-line treatment of adult patients diagnosed with FLT3-mutated acute myeloid leukemia, in combination with specific standard induction followed by consolidation chemotherapy, according to clinical criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
cytarabine,
midostaurin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2018
Guidelines and Advice
Status: Current
Version: 2
Oct 2018
Cancer facts
Oct 2018
Guidelines and Advice
Status: Current
ID: pet 2018-1
Version: n/a
Oct 2018
Guidelines and Advice
Status: In-Review
ID: ES 15-16
Oct 2018